<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-molecules-26-00264">
  <title>Supplementary Materials</title>
  <p>NMR and MS spectra of isolated compounds are available online, Figure S1: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of androsin, Figure S2: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of androsin, Figure S3: ESI-MS (positive ion mode) spectrum of androsin, Figure S4: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of isovitexin, Figure S5: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of isovitexin, Figure S6: ESI-MS (positive ion mode) spectrum of isovitexin, Figure S7: ESI-MS (negative ion mode) spectrum of isovitexin, Figure S8: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of swertisin, Figure S9: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of swertisin, Figure S10: 
   <sup>13</sup>C-NMR spectrum (75 MHz, C
   <sub>5</sub>D
   <sub>5</sub>N) of swertisin, Figure S11: ESI-MS (positive ion mode) spectrum of swertisin, Figure S12: ESI-MS (negative ion mode) spectrum of swertisin, Figure S13: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S14: COSY spectrum of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S15: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S16: HSQC spectrum of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S17: HMBC spectrum of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S18: HMBC spectrum (enlargement 1) of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S19: HMBC spectrum (enlargement 2) of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S20: NOESY spectrum of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S21: ESI-MS spectra (positive and negative ion mode) of 2”-
   <italic>O</italic>-α-
   <sc>l</sc>-rhamnosyl swertisin, Figure S22: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of tryptophan, Figure S23: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of tryptophan, Figure S24: ESI-MS (positive ion mode) spectrum of tryptophan, Figure S25: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of isotectorigenin, Figure S26: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of isotectorigenin, Figure S27: ESI-MS (positive ion mode) spectrum of isotectorigenin, Figure S28: ESI-MS (negative ion mode) spectrum of isotectorigenin, Figure S29: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of 
   <italic>trans</italic>-ε-viniferin, Figure S30: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of 
   <italic>trans</italic>-ε-viniferin, Figure S31: ESI-MS (positive ion mode) spectrum of 
   <italic>trans</italic>-ε-viniferin, Figure S32: ESI-MS (negative ion mode) spectrum of 
   <italic>trans</italic>-ε-viniferin, Figure S33: 
   <sup>1</sup>H-NMR spectrum (300 MHz, CD
   <sub>3</sub>OD) of resveratrol-3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside, Figure S34: 
   <sup>13</sup>C-NMR spectrum (75 MHz, CD
   <sub>3</sub>OD) of resveratrol-3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside, Figure S35: HSQC spectrum of resveratrol 3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside, Figure S36: HMBC spectrum of resveratrol-3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside, Figure S37: NOESY spectrum of resveratrol 3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside, Figure S38: ESY-MS spectrum (positive ion mode) of resveratrol-3,4′-
   <italic>O</italic>-di-β-
   <sc>d</sc>-glucopyranoside.
  </p>
 </app>
</app-group>
